View in EDS

GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

Saved in:

Bibliographic Details
Title:	GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.
Authors:	Maceski, Aleksandra Maleska¹, Benkert, Pascal², Einsiedler, Maximilian¹, Schaedelin, Sabine², Oechtering, Johanna¹, Melie-Garcia, Lester³, Cagol, Alessandro⁴, Galbusera, Riccardo³, Galli, Edoardo¹, Müller, Jannis³
Source:	Brain: A Journal of Neurology; Jul2026, Vol. 149 Issue 7, p2295-2307, 13p
Database:	Applied Science & Technology Source

Description
ISSN:	00068950
DOI:	10.1093/brain/awaf433